Clinical review report Emtricitabine/tenofovir alafenamide fumarate (Descovy)

The objective of this systematic review was to evaluate of the beneficial and harmful effects of the fixed-dose combination of emtricitabine/tenofovir alafenamide fumarate in combination with other antiretrovirals for the treatment of human immunodeficiency virus(HIV)-1 infection in adult and pediat...

Full description

Bibliographic Details
Main Author: Canadian Agency for Drugs and Technologies in Health (author)
Corporate Author: Canadian Agency for Drugs and Technologies in Health, author, issuing body (author)
Format: eBook
Language:Inglés
Published: Ottawa, Ontario : Canadian Agency for Drugs and Technologies in Health 2016.
Subjects:
See on Biblioteca Universitat Ramon Llull:https://discovery.url.edu/permalink/34CSUC_URL/1im36ta/alma991009820283006719
Description
Summary:The objective of this systematic review was to evaluate of the beneficial and harmful effects of the fixed-dose combination of emtricitabine/tenofovir alafenamide fumarate in combination with other antiretrovirals for the treatment of human immunodeficiency virus(HIV)-1 infection in adult and pediatric patients 12 years of age and older (and weighing ≥ 35 kg).
Physical Description:1 online resource (1 PDF file (xiii, 69 pages)) : illustrations